Table 1 Baseline characteristics of study groups with normal glucose tolerance, impaired glucose tolerance and diabetes mellitus as assessed with oral glucose tolerance test at the 3-month follow-up (n = 200).
From: Value of oral glucose tolerance test in the acute phase of myocardial infarction
Overall study population N = 200 | Normal glucose tolerance N = 142 | Impaired glucose tolerance N = 48 | Diabetes mellitus N = 10 | p | |
|---|---|---|---|---|---|
Age (years) | 56.5 ± 8.7 | 54.9 ± 8.3 | 60.6 ± 8.1 | 59.8 ± 8.7 | 0.00012* |
Male n (%) | 155 (77.5) | 112 (78.9) | 35 (83.3) | 8 (80) | NS |
Body mass index (kg/m2) | 27.0 ± 4.0 | 26.3 ± 4.1 | 26.7 ± 4.1 | 28.9 ± 3.1 | NS |
Admission glycemia (mmol/l) | 7.5 ± 1.6 | 7.3 ± 1.5 | 7.8 ± 1.7 | 8.8 ± 1.9 | 0.016** |
HbA1c (%) | 6.0 ± 0.7 | 6.0 ± 0.7 | 5.9 ± 0.6 | 7.1 ± 0.6 | 0.0001** 0.00006*** |
Mean blood glycemia on day 1 (mmol/l) | 6.5 ± 1.0 | 6.4 ± 0.9 | 6.8 ± 0.9 | 7.8 ± 1.6 | 0.03** |
Mean blood glycemia on day 2 (mmol/l) | 6.8 ± 1.0 | 6.6 ± 0.8 | 7.3 ± 1.3 | 7.7 ± 0.7 | 0.002** 0.0003* |
Total cholesterol (mmol/l) | 5.8 ± 1.1 | 5.8 ± 1.1 | 5.9 ± 1.4 | 6.0 ± 1.1 | NS |
LDL cholesterol (mmol/l) | 3.9 ± 1.0 | 3.9 ± 0.9 | 3.8 ± 1.2 | 3.8 ± 0.9 | NS |
HDL cholesterol (mmol/l) | 1.4 ± 0.3 | 1.4 ± 0.3 | 1.4 ± 0.3 | 1.3 ± 0.2 | NS |
Triglycerides (mmol/l) | 1.3 ± 1.1 | 1.2 ± 0.8 | 1.5 ± 1.6 | 2.0 ± 1.6 | NS |
Creatinine (μmol/l) | 84.8 ± 15.4 | 84.8 ± 14.7 | 83.6 ± 16.8 | 91.5 ± 18.5 | NS |
Hypertension (%) | 36.5 | 31.7 | 47.9 | 50 | NS |
Current smoker (%) | 70.5 | 71.8 | 64.6 | 80 | NS |
Family history of premature coronary artery disease (%) | 24.5 | 26.1 | 22.9 | 10 | NS |